Learn More
Amoebic encephalitis is an uncommon and usually fatal condition. This case describes successful treatment of a Balamuthia mandrillaris brain abscess using prolonged antimicrobial agents with complete excision. It illustrates the risk of dissemination from cutaneous to cerebral amoebic lesions, potential progression with corticosteroid therapy, and the(More)
We describe laboratory-confirmed influenza A pandemic (H1N1) 2009 in 17 hospitalized recipients of a hematopoietic stem cell transplant (HSCT) (8 allogeneic) and in 15 patients with malignancy treated at 6 Australian tertiary centers during winter 2009. Ten (31.3%) patients were admitted to intensive care, and 9 of them were HSCT recipients. All recipients(More)
H epatitis C virus (HCV) affects 170 million people worldwide and causes significant morbidity and mortality. 1 In high-income countries , people who inject drugs (PWID) are at greatest risk of HCV infection. 2 Until recently HCV eradica-tion seemed unlikely, but recent advances in HCV treatment and improved understanding of the effectiveness of(More)
—Computation-as-a-Service (CaaS) offerings have gained traction in the last few years due to their effectiveness in balancing between the scalability of Software-as-a-Service and the customisation possibilities of Infrastructure-as-a-Service platforms. To function effectively, a CaaS platform must have three key properties: (i) reactive assignment of(More)
—Audio/visual recognition and retrieval applications have recently garnered significant attention within Internet-of-Things (IoT) oriented services, given that video cameras and audio processing chipsets are now ubiquitous even in low-end embedded systems. In the most typical scenario for such services, each device extracts audio/visual features and(More)
BACKGROUND Hepatitis C treatment uptake in Australia is low. To increase access to hepatitis C virus treatment for people who inject drugs, we developed a community-based, nurse-led service that linked a viral hepatitis service in a tertiary hospital to primary care clinics, and resulted in hepatitis C treatment provision in the community. METHODS A(More)
Testing for hepatitis C virus (HCV) infection may reduce the risk of liver-related morbidity, by facilitating earlier access to treatment and care. This review investigated the effectiveness of targeted testing interventions on HCV case detection, treatment uptake, and prevention of liver-related morbidity. A literature search identified studies published(More)